Answers are grounded in this paper and cite their sources.
Rhesus alloimmunization represents a cause for perinatal morbidity and mortality. In fetal severe anemia due to red blood cell alloimmunization, intrauterine blood transfusion and preterm delivery may be considered as a treatment option. Anti-D should be given within 72 hours after birth to reduce the risk of RhD complications in rhesus-negative women who have given birth to a rhesus-positive child.
No takes yet. Share an insight, caveat, or question.
Cionca et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: